Your Location:
Home >
Browse articles >
A Randomized, Double-blind, Placebo-controlled Clinical Trial of Tengshen Granules for Treatment of Grade 1 Hypertension
A Randomized, Double-blind, Placebo-controlled Clinical Trial of Tengshen Granules for Treatment of Grade 1 Hypertension
- “The clinical efficacy of Tengshen Granules in treating grade 1 hypertension with liver heat and excessive yang, and mild kidney yin deficiency is outstanding. The research team has verified the antihypertensive effect of traditional Chinese medicine compound, opening up a new direction for the integrated treatment of hypertension with traditional Chinese and Western medicine.”
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 32, Issue 21, Pages: 168-176(2026)
DOI: 10.13422/j.cnki.syfjx.20251724
Revised:2025-07-10 ,
Accepted:22 July 2025
Scan QR Code
AI Introduction
Full Text(HTML)
Figs( 1 ) Tabs( 8 )
References
Publication Info
Metrics
318
Views
82
Downloads
0
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Chinese Medicine Regulates Nrf2 Signaling Pathway for Treating Hepatic Fibrosis: A Review
Effect of Shengui Jiangtang Formula on Glucose and Lipid Metabolism in Type 2 Diabetic db/db Mice via PI3K/Akt/FoxO1 Signaling Pathway and Underlying Mechanisms
Research Progress of Traditional Chinese Medicine in Improving Diabetic Retinopathy Based on Nrf2 Signaling Pathway
Traditional Chinese Medicine Intervention in Parkinson's Disease Based on Keap1/Nrf2/ARE Signaling Pathway: A Review
Regulatory Pathways of Cell Apoptosis in Diabetic Kidney Disease and Intervention by Traditional Chinese Medicine: A Review
Related Author
No data
Related Institution
No data


